Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bayer Pharma › Peter Sandner
PS

Peter Sandner — 10 Patents

BPBayer Pharma: 4 patents #199 of 819Top 25%
AGAdverio Pharma Gmbh: 2 patents #23 of 39Top 60%
BHBayer Healthcare: 2 patents #3,312 of 8,007Top 45%
BGBayer Intellectual Property Gmbh: 2 patents #437 of 1,266Top 35%
Wuppertal, DE: #218 of 1,656 inventorsTop 15%
Overall (All Time): #481,000 of 4,157,543Top 15%
10 Patents All Time
Peter Sandner has been granted 10 US patents while listed as an inventor at Bayer Pharma. The first was granted in 2012 and the most recent in January 2025. Peter Sandner ranks #481,000 of 4,157,543 US inventors in our database (top 11.6%). Patent records list Peter Sandner in Wuppertal, DE.

Patents per Year

Patents granted per year, 2012 to 2025Bar chart with a peak of 3 patents in 2022.peak 32012: 1 patents20122015: 1 patents20152019: 2 patents20192021: 1 patents20212022: 3 patents20222023: 1 patents20232025: 1 patents2025

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
12195448 Substituted pyrazolo piperidine carboxylic acids Alexandros Vakalopoulos, Marie-Pierre Collin-Kröpelin, Nuria ORTEGA HERNANDEZ, Andre DIESKAU, Melissa BOULTADAKIS-ARAPINIS +9 more 2025-01-14
11684621 Combination containing sGC stimulators and mineralocorticoid receptor antagonists Peter Kolkhof 2023-06-27
11508483 Method of identifying a subgroup of patients suffering from dcSSc which benefits from a treatment with sGC stimulators and sGC activators in a higher degree than a control group Melanie Hemmrich, Janethe de Oliveira Pena, Stephen Dawe 2022-11-22
11439628 Use of non-steroidal mineralocorticoid receptor antagonists alone or in combination for the treatment of muscular or neuromuscular diseases Peter Kolkhof, Ilka MATHAR, Stefanie Breitenstein 2022-09-13
11331308 Combination containing sGC activators and mineralocorticoid receptor antagonists Peter Kolkhof 2022-05-17
10918639 Combination containing SGC stimulators and mineralocorticoid receptor antagonists Peter Kolkhof 2021-02-16
10265314 SGC stimulators in combination with additional treatment for the therapy of cystic fibrosis Johannes-Peter Stasch, Michael Hahn, Markus Follmann 2019-04-23
10189856 Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc) Claudia Hirth-Dietrich, Johannes-Peter Stasch, Andreas Knorr, Georges Von Degenfeld, Michael Hahn +1 more 2019-01-29
9040566 Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension Jürgen Klar, Georges Von Degenfeld, Hans-Georg Lerchen, Barbara Albrecht-Küpper, Andreas Knorr +1 more 2015-05-26
8304406 Compounds for treating pulmonary hypertension Martina Susanne Klein, Reiner Frey, Bernd Riedl, Olaf Christensen 2012-11-06

Frequent Collaborators

Peter Kolkhof4 shared
Markus Follmann2 shared
Johannes-Peter Stasch2 shared
Ilka MATHAR2 shared
Andreas Knorr2 shared
Georges Von Degenfeld2 shared

Nearby-Ranked Inventors

Ghulam Maharvi10
Alyssa Torjesen10
Stefan Holst10
Paul Bechard10
Yigit Akalan10
Young Suk Oh10
Andreas Josef Zunzer10
Adam W. Kidd10
John Joseph Rahaim10